Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. [electronic resource]
Producer: 20090716Description: 6077-84 p. digitalISSN:- 1528-0020
- Administration, Oral
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Child
- Child, Preschool
- Combined Modality Therapy
- Cranial Irradiation
- Female
- Follow-Up Studies
- Humans
- Immunoenzyme Techniques
- Infant
- Karyotyping
- Male
- Mercaptopurine -- administration & dosage
- Methotrexate -- administration & dosage
- Methyltransferases -- metabolism
- Neoplasms, Second Primary -- chemically induced
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Prognosis
- Remission Induction
- Risk Factors
- Stem Cell Transplantation
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.